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Ru2(CO)4{OOC(CH2)nCH3}2L2 SAWHORSE-TYPE COMPLEXES CONTAINING μ2-η
2
-CARBOXYLATO 
LIGANDS DERIVED FROM SATURATED FATTY ACIDS 
J. P. Johnpeter and B. Therrien 
The thermal reaction of Ru3(CO)12 with the saturated fatty acids (heptanoic, nonanoic, decanoic, 
tridecanoic, tetradecanoic, heptadecanoic, octadecanoic) in refluxing tetrahydrofuran, followed by addition 
of triphenylphosphine (PPh3) or pyridine (C5H5N), gives the dinuclear complexes 
Ru2(CO)4{OOC(CH2)nCH3}2L2 (1: n = 5, 2: n = 7, 3: n = 8, 4: n = 11, 5: n = 12, 6: n = 15, 7: n = 16; 
a: L = NC5H5, b: L = PPh3). The single crystal structure analysis of 1b, 2a, 3a, 4a and 5a reveals a 
dinuclear Ru2(CO)4 sawhorse structure, the diruthenium backbone being bridged by the carboxylato 
ligands, while the two L ligands occupy the axial positions at the ruthenium atoms. In 2a, π–π stacking 
interactions between adjacent pyridyl units of symmetry related molecules prevail, while in the longer alkyl 
chain derivatives 3a, 4a and 5a, additional van der Waals and electrostatic interactions between the alkyl 
chains take place as well in the packing arrangement of the molecules, thus giving rise to layers of parallel 
alkyl chains in the crystal. 
Keywords: carbonyl ligands, carboxylato bridges, fatty acids, dinuclear complexes, ruthenium. 
INTRODUCTION 
Sawhorse-type ruthenium complexes of the type Ru2(CO)4(OOCR)2L2, L being a two-electron donor ligand, are 
well-known since 1969, when J. Lewis and co-workers reported their formation by refluxing Ru3(CO)12 in various carboxylic 
acids followed by depolymerisation of the obtained materials in coordinating solvents [1]. These dinuclear complexes were 
shown later, by a single-crystal X-ray structure analysis of Ru2(CO)4(OOCBu
n)2(PBu3
t )2, to possess a Ru2(CO)4 backbone in 
a sawhorse-type arrangement with two μ2-η
2-carboxylato bridges (OOCBun) and two axial two-electron donor ligands 
(PBu
3
t ) [2]. Since their discovery, a considerable number of such sawhorse-type diruthenium complexes with carboxylato 
bridges have been synthesised and they have been studied in different field of applications [3]. 
Herein, we report the synthesis, characterisation and molecular structure of fourteen new Ru2(CO)4 sawhorse-type 
complexes containing carboxylato ligands derived from saturated fatty acids. The single-crystal structure analysis of five 
representative complexes is presented as well. 
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 Dodecacarbonyltriruthenium reacts with the appropriate carboxylic acid (heptanoic, nonanoic, decanoic, tridecanoic, 
tetradecanoic, heptadecanoic, octadecanoic) in refluxing tetrahydrofuran to give, in the presence of triphenylphosphine or 
pyridine (L), the dinuclear complexes Ru2(CO)4{OOC(CH2)nCH3}2L2 in reasonable yields, see Scheme 1. 
 
2/3Ru3(CO)12 + 2CH3(CH2)nCOOH + 2L → Ru2(CO)4{OOC(CH2)nCH3}2L2 + 4CO + 2H2 
 
L n = 5 n = 7 n = 8 n = 11 n = 12 n = 15 n = 16 
NC5H5 1a 2a 3a 4a 5a 6a 7a 
PPh3 1b 2b 3b 4b 5b 6b 7b 
 
Scheme 1. Synthesis of the dinuclear complexes Ru2(CO)4{OOC(CH2)nCH3}2L2 (1-7). 
 
All compounds are air-stable yellow crystalline powders which have been characterised by their infrared, NMR and 
mass spectrometry as well as by their micro-analytical data. All compounds exhibit in the ν(CO) region of the infrared 
spectrum the characteristic pattern of the Ru2(CO)4 sawhorse unit, which consist of three bands (very-strong; medium; very-
strong) between 2100 cm–1 and 1900 cm–1 [3]. The triphenylphosphine derivatives 1b–7b show in their 31P NMR spectra 
(CDCl3, 23°C) a singlet at ≈15 ppm, typical of a triphenylphosphine ligand being coordinated to a Ru2(CO)4(O2CCR)2 
dinuclear core [4-6]. 
The single-crystal structure analysis of 1b shows as expected a Ru2(CO)4 sawhorse backbone with the two 
triphenylphosphine ligands in the axial positions and the carboxylato bridges in the equatorial positions, see Fig. 1. The Ru–Ru 
distance (2.7239(5) Å) is in the range of a ruthenium-ruthenium single bond, as it was also observed in analogous complexes 
containing triphenylphosphine axial ligands [4-6]. The P–Ru–Ru–P torsion angle is 40.4(2)°, which is comparable to those 
observed in Ru2(CO)4{O2CCH2O–C6H2Cl2–COC(CH2)C2H5}2(PPh3)2 [4] and Ru2(CO)4(O2CC5H4FeC5H5)2(PPh3)2 [6]. 
Similarly, the single-crystal structure analyses of 2a, 3a, 4a, and 5a exhibit the Ru2(CO)4 sawhorse backbone with 
the two pyridyl ligands in the axial positions and the carboxylato bridges in the equatorial positions (Fig. 2). Selected 
geometrical parameters are given in Table 1. The Ru–Ru distances (2a: 2.6804(8) Å, 3a: 2.6817(5) Å, 4a: 2.6793(14) Å, 
5a: 2.6829(5) Å) are as well in the range of a ruthenium-ruthenium single bond but they are considerably shorter than the one 
observed in the triphenylphosphine derivative 1b (Table 1). This difference in the metal–metal distance can be associated to 
an increase in electron density between the metal atoms as a result of the lack of back-bonding to the pyridyl ligands. 
In the crystal packing of 2a, closed parallel π–π stacking interactions is observed between pyridyl groups of two 
adjacent dinuclear complexes (Fig. 3). The centroid-centroid separation is 3.73 Å and agreed well with the theoretical value 
calculated for this π stacking mode [7].  
Similarly, in the crystal packing of 3a, 4a, and 5a, parallel π stacking interactions are observed between 
neighbouring pyridyl moieties of adjacent sawhorse complexes, however, the centroid-centroid separations are slightly 
shorter in these crystals (3a: 3.64 Å, 4a: 3.63 Å, 5a: 3.64 Å). The presence of longer alkyl chains in 3a, 4a and 5a induces 
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 Fig. 1. ORTEP drawing of Ru2(CO)4{OOC(CH2)5CH3}2(PPh3)2 
(1b) at 50% probability level ellipsoids with hydrogen atoms 
omitted for clarity. 
 
TABLE 1. Selected Bond Lengths (Å) and Angles (deg) for 1b, 2a, 3a, 4a, and 5a 
Parameter 1b 2a 3a 4a 5a 
Distances (Å) 
Ru–Ru 2.7239(5) 2.6804(8) 2.6817(5) 2.6793(14) 2.6829(5) 
Ru–PPPh3 2.4566(11)     
Ru–PPPh3 2.4296(11)     
Ru–Npyridine  2.223(6) 2.224(3) 2.246(9) 2.215(4) 
Ru–Npyridine  2.211(6) 2.209(3) 2.206(9) 2.216(4) 
Ru–Ocarboxylato 2.123(3) 2.128(6) 2.148(3) 2.122(8) 2.150(3) 
Ru–Ocarboxylato 2.114(3) 2.120(5) 2.115(3) 2.123(8) 2.118(3) 
Ru–Ocarboxylato 2.138(3) 2.131(6) 2.126(3) 2.136(8) 2.125(4) 
Ru–Ocarboxylato 2.114(3) 2.124(6) 2.127(3) 2.132(8) 2.121(4) 
Angles (deg) 
Ocarboxylato      
O–Ru–O 85.06(14) 83.3(2) 82.81(12) 81.4(4) 82.82(15) 
O–Ru–O 84.32(12) 83.7(2) 83.22(12) 82.3(3) 83.47(16) 
Ccarbonyl      
C–Ru–C 90.2(2) 88.5(4) 88.3(2) 86.7(6) 88.3(2) 
C–Ru–C 88.4(2) 89.4(4) 89.3(2) 88.4(5) 89.4(2) 
Torsion angles (deg) 
L–Ru–Ru–L 40.4(2) –6.5(11) 10.2(5) –6.1(16) 9.0(6) 
 
a different packing arrangement as compared to 2a. Indeed, to maximise van der Waals and electrostatic interactions between 
alkyl chains, and to optimise packing density, the two alkyl chains of the sawhorse complex adopt a parallel arrangement. 
Moreover, these parallel pair of alkyl chains interacts with neighbouring parallel pairs of alkyl chains from symmetry related 
molecules to generate layers of alkyl chains. As an example, the head-to-tail arrangement of parallel alkyl chains observed in 
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Fig. 2. ORTEP drawings of Ru2(CO)4{OOC(CH2)7CH3}2(C5H5N)2 (2a), 
Ru2(CO)4{OOC(CH2)8CH3}2(C5H5N)2 (3a), Ru2(CO)4{OOC(CH2)11CH3}2(C5H5N)2 (4a) and 
Ru2(CO)4{OOC(CH2)12CH3}2(C5H5N)2 (5a) at 50% probability level ellipsoids with hydrogen atoms 
omitted for clarity. 
 
5a is presented in Fig. 4. The width of these layers is approximately 14.0 Å in 3a [Ru–Ru separation], while in 4a it reaches 
17.6 Å and in 5a it is greater than 25.0 Å. 
In conclusion, we have synthesised and characterised fourteen new sawhorse-type complexes containing various n-
alkyl carboxylato bridging ligands. The single-crystal structure analyses of five representatives reveal that for n ≥ 8, the 
packing of the alkyl chains and the π–π interactions between pyridyl groups dominate, while for n ≤ 7, only the arrangement 
of the axial pyridyl ligands plays a significant role in the crystalline packing of these sawhorse-type complexes derived from 
saturated fatty acids. 
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 Fig. 3. Parallel π stacking interaction observed in the 
crystalline packing of 2a. 
 
 
Fig. 4. Main interactions involved in the crystalline packing of 
5a, π stacking interactions between adjacent pyridyl groups and 
van der Waals interactions between parallel alkyl chains. 
EXPERIMENTAL 
General. All manipulations were carried out by routine under nitrogen atmosphere. Organic solvents were degassed 
and saturated with nitrogen prior to use. All fatty acids were purchased either from Aldrich or Fluka and used as received. 
Dodecacarbonyltriruthenium was prepared according to published methods [8]. NMR spectra were recorded on a Bruker 
AvanceII 400 MHz spectrometer. IR spectra were recorded on a Perkin-Elmer 1720X FT-IR spectrometer (4000-400 cm–1). 
Microanalyses were performed by the Laboratory of Pharmaceutical Chemistry, University of Geneva (Switzerland). Electro-
spray mass spectra were obtained in positive-ion mode with a Bruker FTMS 4.7 T BioAPEX II mass spectrometer. 
General method for the preparation of complexes 1-7. A solution of Ru3(CO)12 (100 mg, 0.16 mmol) and the 
appropriate carboxylic acid (0.47 mmol) in dry tetrahydrofuran (25 ml) was heated at 120°C in a pressure Schlenk tube for 
22 h. Then the appropriate axial ligand L (0.47 mmol) was added (L = pyridine 1a-7a, L = triphenylphosphine 1b-7b). The 
solution was stirred at room temperature for 3 hours, evaporated and the product isolated from the residue by crystallisation 
from a tetrahydrofuran/hexane or dichloromethane/pentane mixture. In order to improve the purity, the raw product was 
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 subjected to thin-layer chromatography on silica gel using dichloromethane/pentane as eluents and obtained as yellow 
products. 
Ru2(CO)4{OOC(CH2)5CH3}2(C5H5N)2 (1a). Yellow powder, yield 50 mg (43.74%). 
1H NMR (400 MHz, CDCl3): 
δ = 8.73-8.75 (m, 4H, C5H5N), 7.81-7.85 (tt, 2H, C5H5N, 
3J = 7.6Hz, 4J = 1.6 Hz), 7.44-7.48 (m, 4H, C5H5N), 2.27 (t, 4H, 
CH2COO, 
3J = 7.3 Hz), 1.22-1.24 (m, 20H, CH2), 0.85 (t, 6H, CH3, 
3J = 6.8 Hz). 13C{1H} NMR (100 MHz, CDCl3) 
δ = 205.13 (CO), 195.70 (CO), 183.90 (COO), 151.83 (C5H5N), 36.86 (CH2), 31.83 (CH2), 29.41 (CH2), 29.18 (CH2), 26.62 
(CH2), 14.05 (CH3). IR (KBr): ν(CO) 2021 vs, 1966 m, 1945 m, ν(OCO) 1568 s cm
–1. ESI-MS: m/z = 674.30 [M-2CO]+. Anal. 
Calc. for C54H50N2O8Ru2: C, 45.95; H, 4.87. Found C, 46.02; H, 4.97%. 
Ru2(CO)4{OOC(CH2)5CH3}2(PPh3)2 (1b). Yellow crystalline solid, yield 161 mg (93.87%). 
1H NMR (400 MHz, 
CDCl3): δ = 7.55-7.39 (m, 30H, CHph), 1.94 (t, 4H, CH2COO, 
3J = 7.3 Hz), 0.91-1.40 (m, 16H, CH2), 0.84 (t, 6H, CH3, 
3J = 7.2 Hz). 13C{1H} NMR (100 MHz, CDCl3): δ = 205.13 (CO), 195.70 (CO), 183.90 (COO), 133.87 (CHph), 133.81 
(CHph), 133.75 (CHph), 133.40 (CHph), 129.52 (CHph), 128.03 (CHph), 127.99 (CHph), 37.15 (CH2), 31.52 (CH2), 28.77 (CH2), 
25.67 (CH2), 22.47 (CH2), 22.64 (CH2), 14.04 (CH3). 
31P{1H} NMR (161 MHz, (CDCl3): δ = 14.21 ppm. IR (KBr): ν(CO) 
2024 vs, 1977 m, 1951 m, ν(OCO) 1565 s cm
–1. ESI-MS: m/z = 1015.72 [M-3CO]+. Anal. Calc. for C54H50O8P2Ru2: C, 59.02; 
H, 4.97. Found C, 59.12; H, 5.14%. 
Ru2(CO)4{OOC(CH2)7CH3}2(C5H5N)2 (2a). Yellow crystalline solid, yield 80 mg (65.04%). 
1H NMR (400 MHz, 
CDCl3): δ = 8.75-8.73 (m, 4H, C5H5N), 7.81-7.85 (tt, 2H, C5H5N, 
3J = 7.6Hz, 4J = 1.6 Hz ), 7.40-7.43 (m, 4H, C5H5N), 2.27 
(t, 4H, CH2COO, 
3J = 7.3 Hz), 1.22-1.28 (m, 20H, CH2), 0.87 (t, 6H, CH3, 
3J = 6.9 Hz). 13C{1H} NMR (100 MHz, CDCl3): 
δ = 151.83 (C5H5N), 137.19 (C5H5N), 124.69 (C5H5N), 36.86 (CH2), 31.83 (CH2), 29.41 (CH2), 29.18 (CH2), 26.62 (CH2), 
14.05 (CH3). IR (KBr): ν(CO) 2021 vs, 1968 m, 1945 m, ν(OCO) 1567 s cm
–1. ESI-MS: m/z = 758.76 [M-CO+H]+. Anal. Calc. 
for C58H64N2O8Ru2: C, 48.76; H, 5.66; N, 3.50. Found C, 48.89; H, 5.64; N, 3.56%. 
Ru2(CO)4{OOC(CH2)7CH3}2(PPh3)2 (2b). Yellow crystalline solid, yield 50 mg (27.70%). 
1H NMR (400 MHz, 
CDCl3): δ = 7.55-7.39 (m, 30H, CHph), 1.94 (t, 4H, CH2COO, 
3J = 7.3 Hz), 1.44-0.90 (m, 24H, CH2), 0.87 (t, 6H, CH3, 
3J = 7.1Hz ). 13C{1H} NMR (100 MHz, CDCl3): δ = 205.85 (CO), 188.37 (COO), 151.06 (CO), 133.87 (CHph), 133.81 
(CHph), 133.75 (CHph), 133.25 (CHph), 133.40 (CHph), 133.25 (CHph), 37.16 (CH2), 31.86 (CH2), 29.33 (CH2), 29.18 (CH2), 
29.13 (CH2), 25.74 (CH2), 22.64 (CH2), 14.07 (CH3). 
31P{1H} NMR (161 MHz, CDCl3): δ = 14.22 ppm. IR (KBr): ν(CO) 
2019 vs, 1974 m, 1942 m, ν(OCO) 1559 s cm
–1
. ESI-MS: m/z = 1070.72 [M-3CO]
+
. Anal. Calc. for C64H58O8P2Ru2: 
C, 60.41; H, 5.59. Found C, 60.55; H, 5.66%. 
Ru2(CO)4{OOC(CH2)8CH3}2(C5H5N)2 (3a). Yellow crystalline solid, yield 80 mg (32.00%). 
1H NMR (400 MHz, 
CDCl3): δ = 8.75-8.73 (m, 4H, C5H5N), 7.85-7.81 (m, 2H, C5H5N), 7.43-7.40 (m, 4H, C5H5N), 2.27 (t, 4H, 
CH2COO,
3J = 7.1 Hz), 1.22-1.28 (m, 20H, CH2), 0.88 (t, 6H, CH3, 
3J = 6.9 Hz). 13C{1H} NMR (100 MHz, CDCl3): 
δ = 151.83 (C5H5N), 137.09 (C5H5N), 124.09 (C5H5N), 36.86(CH2), 31.83(CH2), 29.41(CH2), 29.18(CH2), 26.62 (CH2), 
14.05 (CH3). IR (KBr): ν(CO) 2021 vs, 1966 m, 1945 m, ν(OCO) 1568 s cm
–1. ESI-MS: m/z = 759.10 [M-2CO]+. Anal. Calc. for 
C34H68N2O8Ru2: C, 49.12; H, 5.82; N, 3.29. Found C, 50.11; H, 5.94; N, 3.44%. 
Ru2(CO)4{OOC(CH2)8CH3}2(PPh3)2 (3b). Yellow powder, yield 127 mg (69.03%). 
1H NMR (400 MHz, CDCl3): 
δ = 7.55-7.26 (m, 30H, CHph), 1.97 (t, 4H, CH2COO, 
3J = 7.2 Hz), 1.25–0.90 (m, 28H, CH2), 0.92 (t, 6H, CH3, 
3J = 7Hz ). 
13C{1H} NMR (100 MHz, CDCl3): δ = 205.48 (CO), 205.44 (CO), 205.40 (CO), 188.49 (COO), 188.34 (COO), 133.91 
(CHph), 133.85 (CHph), 133.79 (CHph), 133.58 (CHph), 133.42 (CHph), 133.27 (CHph), 37.21 (CH2), 31.93 (CH2), 29.54 (CH2), 
29.44 (CH2), 25.79 (CH2), 22.70 (CH2), 14.16 (CH3). 
31P{1H} NMR (161 MHz, (CDCl3): δ = 14.01 ppm. IR (KBr): ν(CO) 
2018 vs, 1976 m, 1942 m, ν(OCO) 1557 s cm
–1. ESI-MS: m/z = 1180.35[M+H]+. Anal. Calc. for C60H68O8P2Ru2: C, 61.01; H, 
5.80. Found C, 59.98; H, 5.71%. 
Ru2(CO)4{OOC(CH2)11CH3}2(C5H5N)2 (4a). Yellow crystalline solid, yield 85 mg (55.19%). 
1H NMR (400 MHz, 
CDCl3): δ = 8.75-8.73 (m, 4H, C5H5N), 7.85-7.81 (m, 2H, C5H5N), 7.43-7.40 (m, 4H, C5H5N), 2.26 (t, 4H, CH2COO, 
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 3J = 7.1 Hz), 1.25-1.22 (m, 48H, CH2), 0.88 (t, 6H, CH3, 
3J = 7.2 Hz). 13C{1H} NMR (100 MHz, CDCl3): δ = 206.13 (CO), 
195.42 (CO), 183.91 (COO), 151.83 (C5H5N), 36.96 (CH2), 31.84 (CH2), 29.30 (CH2), 29.18 (CH2), 26.26 (CH2), 14.36 
(CH3). IR (KBr): ν(CO) 2022 vs, 1968 m, 1945 m, ν(OCO) 1569 s cm
–1. ESI-MS: m/z = 843.19 [M-2CO]+. Anal. Calc. for 
C40H60N2O8Ru2: C, 53.17; H, 6.53; N, 2.99. Found C, 53.44; H, 6.72; N, 3.11%. 
Ru2(CO)4{OOC(CH2)11CH3}2(PPh3)2 (4b). Yellow powder, yield 85 mg (42.92%). 
1H NMR (400 MHz, CDCl3): 
δ = 7.58-7.26 (m, 30H, CHph), 1.94 (t, 4H, CH2COO, 
3J = 7.2 Hz), 1.28-1.01 (m, 40H, CH2), 0.90 (t, 6H, CH3, 
3J = 6.8 Hz ). 
13C{1H} NMR (100 MHz, CDCl3): δ = 205.48 (CO), 205.46 (CO), 205.42 (CO), 205.38 (CO), 188.47 (COO), 188.39 (COO), 
188.39 (COO), 133.89 (CHph), 133.77 (CHph), 133.56 (CHph), 133.40 (CHph), 133.25 (CHph), 129.54 (CHph), 37.18 (CH2), 
31.92 (CH2), 29.77 (CH2), 29.58 (CH2), 25.43 (CH2), 22.69 (CH2), 14.13 (CH3). 
31 P{1H} NMR: (161 MHz, (CDCl3): 
δ = 14.23 ppm. IR (KBr): ν(CO) 2021 vs, 1974 m, 1943 m, ν(OCO) 1558 s cm
–1. ESI-MS: m/z = 1266.35 [M+H] +. Anal. Calc. 
for C66H80O8P2Ru2: C, 62.64; H, 6.37. Found C, 62.73; H, 6.51%. 
Ru2(CO)4{OOC(CH2)12CH3}2(C5H5N)2 (5a). Yellow crystalline solid, yield 50 mg (34.48%). 
1H NMR (400 MHz, 
CDCl3): δ = 8.75-8.73 (m, 4H, C5H5N), 7.84-7.80 (m, 2H, C5H5N), 7.43-7.40 (m, 4H, C5H5N), 2.28 (t, 4H, CH2COO, 
3J = 7.2 Hz), 1.26-1.22 (m, 48H, CH2), 0.88 (t, 6H, CH3, 
3J = 6.8 Hz). 13C{1H} NMR (100 MHz, CDCl3): δ = 204.10 (CO), 
186.94 (COO), 151.84 (C5H5N), 137.22 (C5H5N), 124.72 (C5H5N), 36.87 (CH2), 31.89 (CH2), 29.68 (CH2), 29.64 (CH2), 
29.58 (CH2), 29.51 (CH2), 29.41 (CH2), 29.34 (CH2), 29.20 (CH2), 29.04 (CH2), 26.19 (CH2), 24.70 (CH2), 22.65 (CH2), 
14.08 (CH3). IR (KBr): ν(CO) 2022 vs, 1969 m, 1944 m, ν(OCO) 1568 s cm
–1. ESI-MS: m/z = 872.22 [M-2CO]+. Anal. Calc. for 
C42H64N2O8Ru2: C, 54.03; H, 6.92; N, 2.91. Found C, 54.41; H, 6.99; N, 3.02%. 
Ru2(CO)4{OOC(CH2)12CH3}2(PPh3)2 (5b). Yellow powder, yield 60 mg (30.28%). 
1H NMR (400 MHz, CDCl3): 
δ = 7.52-7.35 (m, 30H, CHph), 1.91 (t, 4H, CH2COO, 
3J = 7.2 Hz), 1.65-0.90 (m, 44H, CH2), 0.88 (t, 6H, CH3, 
3J = 6.8 Hz). 
13C{1H} NMR (100 MHz, CDCl3): δ = 205.85 (CO), 188.37 (COO), 151.06 (CO), 133.87 (CHph), 133.81 (CHph), 133.75 
(CHph), 133.40 (CHph), 129.51 (CHph), 128.08 (CHph), 37.16 (CH2), 31.89 (CH2), 29.63 (CH2), 29.56 (CH2), 29.33 (CH2), 
25.74 (CH2), 22.65 (CH2), 14.08 (CH3). 
31P{1H} NMR (161 MHz, CDCl3): δ = 14.21 ppm. IR (KBr): ν(CO) 2031 vs, 1981 m, 
1952 m, ν(OCO) 1559 s cm
–1. ESI-MS: m/z = 1266.40 [M-CO]+. Anal. Calc. for C68H84O8P2Ru2: C, 63.16; H, 6.53. Found C, 
63.14; H, 6.55%. 
Ru2(CO)4{OOC(CH2)15CH3}2(C5H5N)2 (6a). Yellow powder, yield 50 mg (43.74%). 
1H NMR (400 MHz, CDCl3): 
δ = 8.75-8.73 (m, 4H, C5H5N), 7.84-7.80 (tt, 2H, C5H5N, 
3J = 7.6Hz, 4J = 1.6 Hz), 7.43-7.40 (ddd, 4H, C5H5N, 
3J = 7.6 Hz, 
3J = 4.9 Hz, 4J = 1.4 Hz), 2.26 (t, 4H, CH2COO, 
3J = 7.2 Hz), 1.26–1.22 (m, 48H, CH2), 0.88 (t, 6H, CH3, 
3J = 6.8 Hz). 
13C{1H} NMR (100 MHz, CDCl3): δ = 204.12 (CO), 186.84 (COO), 151.84 (C5H5N), 137.21 (C5H5N), 124.71 (C5H5N), 
36.87 (CH2), 31.89 (CH2), 29.69 (CH2), 29.63 (CH2), 26.59 (CH2), 26.20 (CH2), 22.66 (CH2), 14.36 (CH3). IR (KBr): ν(CO) 
2022 vs, 1969 m, 1946 m, ν(OCO) 1567 s cm
–1. ESI-MS: m/z = 955.33 [M-2CO]+. Anal. Calc. for C48H76N2O8Ru2: C, 57.03; H, 
7.58; N, 3.02. Found C, 57.01; H, 7.58; N, 3.02%. 
Ru2(CO)4{OOC(CH2)15CH3}2(PPh3)2 (6b). Yellow powder, yield 170 mg (78.92%). 
1H NMR (400 MHz, CDCl3): 
δ = 7.57-7.35 (m, 30H, CHph), 1.92 (t, 4H, CH2COO, 
3J = 7.26 Hz), 1.26-0.90 (m, 56H, CH2), 0.86 (t, 6H, CH3, 
3J = 6.76 Hz). 
13C{1H} NMR (100 MHz, CDCl3): δ = 205.85(CO), 188.37 (COO), 133.87 (CHph), 133.81 (CHph), 133.75 (CHph), 133.40 
(CHph), 129.51 (CHph), 128.08 (CHph), 128.03 (CHph), 127.99 (CHph), 37.16 (CH2), 31.89 (CH2), 29.63 (CH2), 29.41 (CH2), 
29.33 (CH2), 25.74 (CH2), 22.65 (CH2), 14.08 (CH3). 
31P{1H} NMR (161 MHz, (CDCl3): δ = 14.21 ppm. IR (KBr): ν(CO) 
2022 vs, 1978 m, 1952 m, ν(OCO) 1567 s cm
–1. ESI-MS: m/z = 1347.93 [M-CO]+. Anal. Calc. for C74H96O8P2Ru2: C, 64.59; H, 
7.13. Found C, 64.52; H, 7.02%. 
Ru2(CO)4{OOC(CH2)16CH3}2(C5H5N)2 (7a). Yellow powder, yield 50 mg (30.80%). 
1H NMR (400 MHz, CDCl3): 
δ = 8.75-8.73 (m, 4H, C5H5N), 7.84-7.80 (m, 2H, C5H5N), 7.43-7.40 (m, 4H, C5H5N), 2.26 (t, 4H, CH2COO, 
3J = 7.2 Hz), 
1.26-1.22 (m, 48H, CH2), 0.88 (t, 6H, CH3, 
3J = 6.8 Hz). 13C{1H} NMR (100 MHz, CDCl3) δ = 186.83 (COO), 151.83 
(C5H5N), 137.91 (C5H5N), 124.19 (C5H5N), 36.87 (CH2), 31.88 (CH2), 29.68 (CH2), 29.58 (CH2), 26.51 (CH2), 29.19 (CH2), 
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 TABLE 2. Crystallographic and Structure Refinement Parameters for Complexes 1b, 2a, 3a, 4a, and 5a 
Parameter 1b 2a 3a 4a 5a 
Chemical formula C54H56O8P2Ru2 C32H44N2O8Ru2 C34H48N2O8Ru2 C40H60N2O8Ru2 C42H64N2O8Ru2 
Formula weight 1097.07 786.83 814.88 899.04 927.09 
Crystal system Triclinic Triclinic Triclinic Triclinic Triclinic 
Space group P-1 (No. 2) P-1 (No. 2) P-1 (No. 2) P-1 (No. 2) P-1 (No. 2) 
Crystal colour and shape yellow block yellow block yellow block yellow block yellow block 
Crystal size 0.23×0.19×0.16 0.25×0.22×0.18 0.22×0.18×0.15 0.16×0.13×0.11 0.24×0.21×0.16 
a, Å 13.2493(13) 10.6836(8) 10.6712(6) 10.6008(14) 10.6356(7) 
b, Å 14.4189(14) 11.2916(9) 11.3078(7) 10.9131(17) 11.1666(8) 
c, Å 15.0855(15) 15.8511(13) 16.3035(11) 18.886(3) 19.3877(15) 
α, deg 106.912(11) 69.609(6) 78.011(5) 94.899(13) 88.198(6) 
β, deg 93.503(12) 82.296(6) 84.539(5) 96.721(12) 89.544(6) 
γ, deg 109.986(11) 77.458(6) 76.100(4) 101.726(12) 76.654(6) 
V, Å3 2549.6(4) 1746.0(2) 1865.9(2) 2111.1(5) 2239.3(3) 
Z 2 2 2 2 2 
T, K 173(2) 173(2) 173(2) 173(2) 173(2) 
dc, g⋅cm
–3 1.429 1.497 1.450 1.414 1.375 
μ, mm–1 0.707 0.913 0.858 0.765 0.724 
Scan range, deg 2.17 < θ < 26.18 1.96 < θ < 29.19 1.89 < θ < 29.19 1.92 < θ < 29.37 1.88 < θ < 29.19 
Unique reflections 9374 9140 10080 11378 12099 
Reflections used [I > 2σ(I)] 6441 4338 6410 3606 7893 
Rint 0.0433 0.1547 0.1053 0.2887 0.1744 
Final R indices [I > 2σ(I)]* 0.0370,  
wR2 0.0879 
0.0795,  
wR2 0.1691 
0.0529,  
wR2 0.0837 
0.1064,  
wR2 0.2178 
0.0680,  
wR2 0.1419 
R indices (all data) 0.0658,  
wR2 0.1115 
0.1783,  
wR2 0.1388 
0.1041,  
wR2 0.0943 
0.2762,  
wR2 0.2874 
0.1120,  
wR2 0.1574 
GOOF 1.010 0.929 0.928 0.862 0.967 
Max, Min Δρ, e⋅Å–3 0.836, –1.314 0.930, –0.839 0.947, –0.857 1.722, –1.187 0.687, –1.219 
 
 
*Structures were refined on 2
0
F : wR2 = [∑[w(
2
0
F  – 2
c
F )2]/∑w( 2
0
F )2]1/2, where w–1 = [∑( 2
0
F ) + (aP)2 + bP] and 
P = [max( 2
0
F , 0) + 2 2
c
F ]/3. 
 
26.19 (CH2), 22.64 (CH2), 14.05 (CH3). IR (KBr): ν(CO) 2022 vs, 1969 m, 1945 m, ν(OCO) 1568 s cm
–1. ESI-MS: m/z = 1012.6 
[M-CO]+. Anal. Calc. for C50H80N2O8Ru2: C, 57.89; H, 7.82; N, 2.58. Found C, 57.78; H, 7.76; N, 2.70%. 
Ru2(CO)4{OOC(CH2)16CH3}2(PPh3)2 (7b). Yellow powder, yield 113 mg (34.23%). 
1H NMR (400 MHz, CDCl3): 
δ = 7.56-7.54 (m, 12H, CHph), 7.52-7.37 (t, 18H, CHph), 1.92 (t, 4H, CH2COO, 
3J = 7.3 Hz), 1.26-0.90 (m, 64H, CH2), 0.88 
(t, 6H, CH3, 
3J = 6.8 Hz). 13C{1H} NMR (100 MHz, CDCl3): δ = 205.85 (CO), 188.37 (COO), 133.87 (CHph), 133.81 (CHph), 
133.75 (CHph), 133.25 (CHph), 133.40 (CHph), 133.25 (CHph), 37.16 (CH2), 31.89 (CH2), 29.63 (CH2), 29.41 (CH2), 29.33 
(CH2), 25.74 (CH2), 22.65 (CH2), 14.08 (CH3). 
31P{1H} NMR (161 MHz, CDCl3): δ = 14.21 ppm. IR (KBr): ν(CO) 2033 vs, 
1982 m, 1950 m, ν(OCO) 1567 s cm
–1. ESI-MS: m/z = 1348.88 [M-2CO]+. Anal. Calc. for C76H100O8P2Ru2: C, 65.00; H, 7.27. 
Found C, 64.94; H, 7.17%. 
X-ray crystallography. Crystals of complexes 1b, 2a, 3a, 4a, and 5a were mounted on a Stoe Image Plate 
Diffraction system equipped with a φ circle goniometer, using MoKα graphite monochromated radiation (λ = 0.71073 Å) with 
φ range 0-200°. The structures were solved by direct methods using the program SHELXS-97, while the refinement and all 
further calculations were carried out using SHELXL-97 [9]. The H-atoms were found on Fourier difference map or included 
8
 in calculated positions and treated as riding atoms using the SHELXL default parameters. The non-H atoms were refined 
anisotropically, using weighted full-matrix least-square on F2. Crystallographic details are summarised in Table 2. Figs. 1 and 
2 were drawn with ORTEP [10]. 
SUPPLEMENTARY DATA 
CCDC 765243 (1b), 765244 (2a), 765245 (3a), 765246 (4a), and 765247 (5a) contain the supplementary 
crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data 
Centre via www.ccdc.cam.ac.uk/data_request/cif. 
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